Nanobodies targeting the tumor microenvironment and their formulation as nanomedicines by Liudmyla Maksymova, Yannick A. Pilger, Lutz Nuhn, Jo A. Van Ginderachter

Get full text

Macrophages, PPARs, and Cancer by Jo A. Van Ginderachter, Kiavash Movahedi, Jan Van den Bossche, Patrick De Baetselier

Get full text

Ablation of NK Cell Function During Tumor Growth Favors Type 2-Associated Macrophages, Leading to Suppressed CTL Generation by Anja B. Geldhof, Jo A. van Ginderachter, Yuanqing Liu, Wim Noël, Patrick de Baetselier

Get full text

Development and evaluation of a single domain antibody targeting folate receptor alpha for radioligand therapy by Jonatan Dewulf, Sam Massa, Laurent Navarro, Yana Dekempeneer, Francis Santens, Hannelore Ceuppens, Karine Breckpot, Jo A. Van Ginderachter, Tony Lahoutte, Matthias D’Huyvetter, Nick Devoogdt

Get full text

Epigenomic preconditioning of peripheral monocytes determines their transcriptional response to the tumor microenvironment by Máté Kiss, Laszlo Halasz, Eva Hadadi, Wilhelm K. Berger, Petros Tzerpos, Szilard Poliska, Daliya Kancheva, Aurélie Gabriel, Romina Mora Barthelmess, Ayla Debraekeleer, Jan Brughmans, Yvon Elkrim, Liesbet Martens, Yvan Saeys, Bence Daniel, Zsolt Czimmerer, Damya Laoui, Laszlo Nagy, Jo A. Van Ginderachter

Get full text